Advances in sequencing technology have made multigene testing, or “panel testing,” a practical option when looking for genetic variants that may be associated with a risk of breast cancer. In June
Cancers, Free Full-Text
A research-based gene panel to investigate breast, ovarian and prostate cancer genetic risk
Software-assisted manual review of clinical NGS data: an alternative to routine Sanger sequencing confirmation with equivalent results in >15,000 hereditary cancer screens
The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families
Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations, BMC Cancer
Landscape of pathogenic variations in a panel of 34 genes and cancer risk estimation from 5131 HBOC families - ScienceDirect
Construction of stemness gene score by bulk and single-cell transcriptome to characterize the prognosis of breast cancer
Cureus Genetic Variation and the Role of Multigene Panel Testing for Hereditary Breast Cancer: A Single-Institution Experience
BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors - ScienceDirect
Mutational signatures for breast cancer diagnosis using artificial intelligence, Journal of the Egyptian National Cancer Institute
A Population-Based Study of Genes Previously Implicated in Breast Cancer
BREAST CANCER. END OF ERA FOR BRCA1 / 2 AND NGS PANELS. NEW ERA with POLYGENIC RISK SCORE
Profile of Pathogenic Mutations and Evaluation of Germline Genetic Testing Criteria in Consecutive Breast Cancer Patients Treated at a North Indian Tertiary Care Center
